{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:32:37Z","timestamp":1768008757242,"version":"3.49.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,15]]},"DOI":"10.1093\/aje\/kwp345","type":"journal-article","created":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T02:22:47Z","timestamp":1259979767000},"page":"177-188","source":"Crossref","is-referenced-by-count":112,"title":["Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project"],"prefix":"10.1093","volume":"171","author":[{"given":"Sharon K.","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kulldorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Fireman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy A.","family":"Lieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"issue":"17","key":"key\n\t\t\t\t20170522113153_bib1","first-page":"453","volume":"58","author":"Update: novel influenza A (H1N1) virus infections\u2014worldwide, May 6, 2009","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"38","key":"key\n\t\t\t\t20170522113153_bib2","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1016\/j.vaccine.2009.06.034","article-title":"Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. World Health Organization H1N1 Vaccine Task Force","volume":"27","author":"Collin","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522113153_bib3","volume-title":"Influenza A (H1N1) 2009 Monovalent","author":"Center for Biologics Evaluation and Research, US Food and Drug Administration","year":"2009"},{"issue":"RR-10","key":"key\n\t\t\t\t20170522113153_bib4","first-page":"1","volume":"58","author":"Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"RR-8","key":"key\n\t\t\t\t20170522113153_bib5","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"58","author":"Fiore","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"suppl 2","key":"key\n\t\t\t\t20170522113153_bib6","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/507556","article-title":"Universal influenza vaccination in the United States: are we ready? Report of a meeting","volume":"194","author":"Schwartz","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"key\n\t\t\t\t20170522113153_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.7.1.75","article-title":"Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience","volume":"7","author":"Iskander","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170522113153_bib8","article-title":"Vaccine monitoring and data collection. (Section S6-III.B3)","volume-title":"HHS Pandemic Influenza Plan. Supplement 6. Vaccine Distribution and Use","author":"US Department of Health and Human Services","year":"2005"},{"issue":"1","key":"key\n\t\t\t\t20170522113153_bib9","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"key\n\t\t\t\t20170522113153_bib10","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"issue":"32","key":"key\n\t\t\t\t20170522113153_bib11","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.vaccine.2009.05.036","article-title":"An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink","volume":"27","author":"Yih","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"key\n\t\t\t\t20170522113153_bib12","first-page":"258","volume":"57","author":"Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170522113153_bib13","article-title":"Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent rotavirus vaccine (RotaTeq)","author":"Belongia","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"key\n\t\t\t\t20170522113153_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jech.56.12.951","article-title":"Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications","volume":"56","author":"Hak","year":"2002","journal-title":"J Epidemiol Community Health"},{"issue":"9636","key":"key\n\t\t\t\t20170522113153_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(08)61160-5","article-title":"Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study","volume":"372","author":"Jackson","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"key\n\t\t\t\t20170522113153_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amepre.2009.08.022","article-title":"Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites","volume":"37","author":"Greene","year":"2009","journal-title":"Am J Prev Med"},{"issue":"1","key":"key\n\t\t\t\t20170522113153_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2307\/2533328","article-title":"Relative incidence estimation from case series for vaccine safety evaluation","volume":"51","author":"Farrington","year":"1995","journal-title":"Biometrics"},{"issue":"10","key":"key\n\t\t\t\t20170522113153_bib18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/07350015.1995.10524589","article-title":"Natural and quasi-experiments in economics","volume":"13","author":"Meyer","year":"1995","journal-title":"J Bus Econ Stat"},{"issue":"11","key":"key\n\t\t\t\t20170522113153_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpedi.158.11.1031","article-title":"Safety of the trivalent inactivated influenza vaccine among children: a population-based study","volume":"158","author":"France","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"16","key":"key\n\t\t\t\t20170522113153_bib21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old","volume":"296","author":"Hambidge","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t20170522113153_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain-Barr\u00e9 syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"5","key":"key\n\t\t\t\t20170522113153_bib23","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.106.5.e62","article-title":"Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination [electronic article]","volume":"106","author":"Virtanen","year":"2000","journal-title":"Pediatrics"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"15-16","key":"key\n\t\t\t\t20170522113153_bib25","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"Farrington","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522113153_bib26","article-title":"Rapid cycle analysis of vaccine safety data [abstract]","author":"Davis"},{"key":"key\n\t\t\t\t20170522113153_bib27","volume-title":"A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance. (Working paper)","author":"Kulldorff","year":"2009"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib28","first-page":"186","article-title":"The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA","volume":"78","author":"Chen","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"5","key":"key\n\t\t\t\t20170522113153_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"The Vaccine Safety Datalink Project","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1542\/peds.2004-1519","article-title":"Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the Vaccine Adverse Event Reporting System, 1990\u20132003","volume":"115","author":"McMahon","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"key\n\t\t\t\t20170522113153_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00312965","article-title":"Meningoencephalitis syndrome following influenza vaccination","volume":"217","author":"Gross","year":"1978","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170522113153_bib32","article-title":"Influenza vaccine and neurological adverse events: VAERS 7\/1990\u20131\/2003 [abstract]. Presented at the meeting","volume-title":"\u201cImmunization Safety Review: Influenza Vaccine and Possible Neurological Complications,\u201d","author":"Haber"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2169\/internalmedicine.42.191","article-title":"Neurologic complications associated with influenza vaccination: two adult cases","volume":"42","author":"Nakamura","year":"2003","journal-title":"Intern Med"},{"issue":"8","key":"key\n\t\t\t\t20170522113153_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"15","key":"key\n\t\t\t\t20170522113153_bib35","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.vaccine.2006.10.006","article-title":"Bell's palsy associated with influenza vaccination: two case reports","volume":"25","author":"Chou","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ageing\/afm151","article-title":"Post-influenza vaccine chronic inflammatory demyelinating polyneuropathy","volume":"37","author":"Brostoff","year":"2008","journal-title":"Age Ageing"},{"issue":"5","key":"key\n\t\t\t\t20170522113153_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-9394(14)70918-3","article-title":"Optic neuritis after influenza vaccination","volume":"124","author":"Hull","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"key\n\t\t\t\t20170522113153_bib38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/jnnp.2003.028902","article-title":"Severe vasculitic neuropathy following influenza vaccination","volume":"75","author":"Hull","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"key\n\t\t\t\t20170522113153_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1620\/tjem.158.95","article-title":"Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy","volume":"158","author":"Saito","year":"1989","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"key\n\t\t\t\t20170522113153_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"key\n\t\t\t\t20170522113153_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000112507","article-title":"Anaphylaxis from the influenza virus vaccine","volume":"146","author":"Coop","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"key\n\t\t\t\t20170522113153_bib42","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/00007611-197910000-00033","article-title":"Urticaria subsequent to administration of influenza vaccine","volume":"72","author":"Horowitz","year":"1979","journal-title":"South Med J"},{"issue":"20","key":"key\n\t\t\t\t20170522113153_bib43","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"20","key":"key\n\t\t\t\t20170522113153_bib45","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t20170522113153_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","article-title":"Neurological adverse events associated with vaccination","volume":"15","author":"Piyasirisilp","year":"2002","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"key\n\t\t\t\t20170522113153_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/14760584.6.4.635","article-title":"The complex link between immunization against childhood diseases and allergy","volume":"6","author":"Kalaboka","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"key\n\t\t\t\t20170522113153_bib48","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2004.09.007","article-title":"Mechanistic actions of the risks and adverse events associated with vaccine administration","volume":"114","author":"Moylett","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"key\n\t\t\t\t20170522113153_bib49","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.1996.00440130090009","article-title":"Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial","volume":"156","author":"Nichol","year":"1996","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522113153_bib50","article-title":"Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection","author":"Moore","year":"2009","journal-title":"J Clin Epidemiol."},{"key":"key\n\t\t\t\t20170522113153_bib51","article-title":"A conditional maximized sequential probability ratio test for pharmacovigilance","author":"Li","journal-title":"Stat Med"},{"issue":"RR-8","key":"key\n\t\t\t\t20170522113153_bib52","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Harper","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR-10","key":"key\n\t\t\t\t20170522113153_bib53","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Smith","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-6","key":"key\n\t\t\t\t20170522113153_bib54","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Fiore","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"key\n\t\t\t\t20170522113153_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oxfordjournals.aje.a112273","article-title":"Comparative trial of influenza vaccines. II. Adverse reactions in children and adults","volume":"104","author":"Barry","year":"1976","journal-title":"Am J Epidemiol"},{"issue":"6910","key":"key\n\t\t\t\t20170522113153_bib56","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.307.6910.988","article-title":"Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial","volume":"307","author":"Govaert","year":"1993","journal-title":"BMJ"},{"issue":"15","key":"key\n\t\t\t\t20170522113153_bib57","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522113153_bib58","article-title":"MaxSPRT-based repeated interval estimates of event rate ratios for independent concurrent comparison populations [abstract]","author":"Mullooly"},{"issue":"2","key":"key\n\t\t\t\t20170522113153_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0038-1633855","article-title":"Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety","volume":"43","author":"Mullooly","year":"2004","journal-title":"Methods Inf Med"},{"issue":"4","key":"key\n\t\t\t\t20170522113153_bib60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3414\/ME0500","article-title":"Predictive value of ICD-9-CM codes used in vaccine safety research","volume":"47","author":"Mullooly","year":"2008","journal-title":"Methods Inf Med"},{"issue":"39","key":"key\n\t\t\t\t20170522113153_bib61","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1016\/j.vaccine.2009.06.092","article-title":"Predictive value of seizure ICD-9 codes for vaccine safety research","volume":"27","author":"Shui","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"key\n\t\t\t\t20170522113153_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMp0905338","article-title":"The new Sentinel Network\u2014improving the evidence of medical-product safety","volume":"361","author":"Platt","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20170522113153_bib63","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"7","key":"key\n\t\t\t\t20170522113153_bib64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.1390","article-title":"Evaluating adverse events after vaccination in the Medicare population","volume":"16","author":"Burwen","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522113153_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/MLR.0b013e3181b58b5c","article-title":"Active influenza vaccine safety surveillance: potential within a healthcare claims environment","author":"Brown","year":"2009","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170522113153_bib66","article-title":"Three years of rapid cycle analysis\u2014what we've learned and what remains to be done [abstract]","author":"Yih"},{"key":"key\n\t\t\t\t20170522113153_bib67","article-title":"H1N1 vaccine safety monitoring: beyond background rates","author":"DeStefano","year":"2009","journal-title":"Lancet"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/171\/2\/177\/17338309\/kwp345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:47:00Z","timestamp":1710722820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kwp345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,4]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2010,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwp345","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,4]]}}}